Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Hikma Pharmaceuticals Plc    HIK   GB00B0LCW083

Delayed Quote. Delayed  - 09/23 05:35:25 pm
2096 GBp   -0.47%
09/22 DIRECTOR DEALIN : Hikma Directors Up Stake As Darhold Acquires Share..
09/20 HIKMA PHARMACEU : Board appointment and succession
09/15 DIRECTOR DEALIN : Hikma Directors Up Stake As Darhold Acquires Share..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

DIRECTOR DEALINGS: Hikma Directors Up Stake As Darhold Acquires Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/22/2016 | 05:09pm CEST

LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Darhold Ltd, a company in which some of its directors are interested, purchased a total of 150,000 shares at a price of 2,138 pence per share on Thursday.

Chairman and Chief Executive Said Darwazah, Executive Vice Chairman Mazen Darwazah and Non-Executive Director Mohammed Al-Husry each acquired 50,000 shares.

Said Darwazah is a shareholder in Darhold with an equity interest of 21.49%, Mazen Darwazah holds a 10.82% stake and Mohammed Al-Husry has a 7.95% stake. All three are directors of Darhold.

Hikma did not reveal the stake held by the three directors or Darhold after the transaction.

The stock was down 0.4% to 2,104.00p per share on Thursday.

Copyright 2016 Alliance News Limited. All Rights Reserved., source Alliance News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HIKMA PHARMACEUTICALS PLC
09/22 DIRECTOR DEALINGS : Hikma Directors Up Stake As Darhold Acquires Shares
09/20 HIKMA PHARMACEUTICALS : Board appointment and succession
09/15 DIRECTOR DEALINGS : Hikma Directors Up Stake As Darhold Acquires Shares
09/14 HIKMA PHARMACEUTICALS : *jpmorgan cuts hikma pharmaceutical target to 2,450 (2,5..
09/12 HIKMA PHARMACEUTICALS : *jefferies cuts hikma pharmaceutical price target to 2,5..
09/11 HIKMA PHARMACEUTICALS : to establish factory in Kazakhstan
09/08 DIRECTOR DEALINGS : Hikma Directors Up Stake As Darhold Buys Shares
09/07 HIKMA PHARMACEUTICALS : MoU Between AUB and Hikma Pharmaceuticals PLC
09/01 HIKMA PHARMACEUTICALS : Director/PDMR Shareholding
09/01 HIKMA PHARMACEUTICALS PLC : ex-dividend day for interim dividend
More news
Sector news : Pharmaceuticals - NEC
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/23 Endo International CEO steps down, Campanelli named successor
09/23DJSHIRE : Files 8K - Direct Or Off-Balance Sheet Financial Obligation
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/24 Hikma Pharmaceuticals' (HKMPF) CEO Said Darwazah on Q2 2016 Results - Earning..
08/24 Hikma Pharmaceuticals reports H1'16 results
03/16 Hikma Pharmaceuticals' (HKMPF) CEO Said Darwazah on Q4 2015 Results - Earning..
03/16 Hikma Pharmaceuticals reports FY'15 results
2015 PREMARKET BIOTECH DIGEST : Merck Earnings, Gilead Beats Again, NantKwest Surges
Advertisement
Financials ($)
Sales 2016 2 046 M
EBIT 2016 364 M
Net income 2016 166 M
Debt 2016 653 M
Yield 2016 0,89%
P/E ratio 2016 33,84
P/E ratio 2017 18,63
EV / Sales 2016 3,53x
EV / Sales 2017 2,91x
Capitalization 6 574 M
More Financials
Chart HIKMA PHARMACEUTICALS PLC
Duration : Period :
Hikma Pharmaceuticals Plc Technical Analysis Chart | HIK | GB00B0LCW083 | 4-Traders
Full-screen chart
Technical analysis trends HIKMA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 34,1 $
Spread / Average Target 25%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Saaid Samih Taleb Darwazah Chairman & Chief Executive Officer
Khalid Nabilsi Chief Financial Officer
Ibrahim Jalal Senior Vice President-Technical Affairs
Ragheb Al-Shakhshir Vice President-Research & Development
Michael Richard Dwyer Ashton Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HIKMA PHARMACEUTICALS ..-8.91%6 574
JOHNSON & JOHNSON15.66%325 050
ROCHE HOLDING LTD.-11.18%218 395
NOVARTIS AG-8.70%214 744
PFIZER INC.6.13%207 809
MERCK & CO., INC.19.20%174 098
More Results